Total Payments
$2,907
2024 Payments
$212.04
Companies
30
Transactions
171
Medicare Patients
2,488
Medicare Billing
$172,215
Payment Breakdown by Category
Food & Beverage$2,880 (99.1%)
Education$27.27 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,880 | 170 | 99.1% |
| Education | $27.27 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $310.76 | 20 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $302.61 | 20 | $0 (2021) |
| ABBVIE INC. | $272.81 | 14 | $0 (2022) |
| PFIZER INC. | $259.76 | 9 | $0 (2024) |
| Novo Nordisk Inc | $215.60 | 17 | $0 (2024) |
| Allergan, Inc. | $167.41 | 11 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $166.87 | 10 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $164.88 | 11 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $126.68 | 10 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $121.39 | 8 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $212.04 | 7 | Hologic Sales and Service, LLC ($88.14) |
| 2023 | $220.98 | 5 | PFIZER INC. ($148.72) |
| 2022 | $116.11 | 6 | Organon LLC ($50.52) |
| 2021 | $225.63 | 14 | Amgen Inc. ($96.06) |
| 2020 | $373.15 | 28 | Novo Nordisk Inc ($128.98) |
| 2019 | $460.94 | 29 | Mylan Specialty L.P. ($86.66) |
| 2018 | $486.18 | 32 | Boehringer Ingelheim Pharmaceuticals, Inc. ($105.00) |
| 2017 | $812.21 | 50 | AstraZeneca Pharmaceuticals LP ($170.69) |
All Payment Transactions
171 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/27/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $88.14 | General |
| Category: Diagnostics | ||||||
| 07/23/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $24.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | PFIZER INC. | PREVNAR 20 (Biological), ABRYSVO, PENBRAYA | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: VACCINES | ||||||
| 05/02/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $18.71 | General |
| Category: Insulin Pump | ||||||
| 04/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.17 | General |
| 09/29/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: RESPIRATORY | ||||||
| 09/27/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $86.83 | General |
| Category: VACCINES | ||||||
| 05/08/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $28.86 | General |
| Category: PSYCHIATRY | ||||||
| 04/06/2023 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 01/17/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $61.89 | General |
| Category: VACCINES | ||||||
| 08/04/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/06/2022 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: ETONOGESTREL | ||||||
| 07/06/2022 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: ETONOGESTREL | ||||||
| 06/06/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Bone Health | ||||||
| 03/09/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Bone Health | ||||||
| 11/23/2021 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/23/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/06/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Bone Health | ||||||
| 08/25/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.07 | General |
| 08/23/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Bone Health | ||||||
| 08/05/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 223 | 386 | $63,452 | $27,382 |
| 2022 | 3 | 116 | 224 | $34,096 | $12,817 |
| 2021 | 9 | 263 | 493 | $76,826 | $32,666 |
| 2020 | 31 | 1,886 | 3,015 | $314,856 | $99,351 |
Total Patients
2,488
Total Services
4,118
Medicare Billing
$172,215
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 99 | 205 | $29,750 | $13,016 | 43.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 51 | 74 | $15,752 | $7,078 | 44.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 30 | 63 | $9,071 | $3,815 | 42.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 20 | $5,417 | $1,990 | 36.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 23 | 24 | $3,463 | $1,482 | 42.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 81 | 168 | $24,380 | $9,557 | 39.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 17 | 32 | $4,607 | $1,719 | 37.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 24 | $5,109 | $1,542 | 30.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 101 | 245 | $35,474 | $16,141 | 45.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 34 | 54 | $11,494 | $5,004 | 43.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 32 | 69 | $9,935 | $3,883 | 39.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 11 | 32 | $6,588 | $2,589 | 39.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 17 | 19 | $5,146 | $1,928 | 37.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 24 | 26 | $3,751 | $1,470 | 39.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 13 | 13 | $2,748 | $927.73 | 33.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 15 | 16 | $1,404 | $665.10 | 47.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 16 | 19 | $285.00 | $57.00 | 20.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 212 | 570 | $136,800 | $39,699 | 29.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 123 | 227 | $34,050 | $11,311 | 33.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 50 | 50 | $7,750 | $5,731 | 73.9% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 88 | 91 | $6,370 | $5,507 | 86.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 27 | 76 | $11,400 | $4,386 | 38.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2020 | 159 | 237 | $17,775 | $3,126 | 17.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2020 | 190 | 286 | $20,020 | $3,001 | 15.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 15 | 16 | $6,400 | $2,587 | 40.4% |
About Dr. Richard David, MD
Dr. Richard David, MD is a Family Medicine healthcare provider based in Athens, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1104821800.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard David, MD has received a total of $2,907 in payments from pharmaceutical and medical device companies, with $212.04 received in 2024. These payments were reported across 171 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($2,880).
As a Medicare-enrolled provider, David has provided services to 2,488 Medicare beneficiaries, totaling 4,118 services with total Medicare billing of $172,215. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Athens, TX
- Active Since 06/17/2005
- Last Updated 04/18/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1104821800
Products in Payments
- FARXIGA (Drug) $233.85
- EVENITY (Biological) $200.61
- PREVNAR 20 (Biological) $167.30
- ENTRESTO (Drug) $164.88
- Ozempic (Drug) $125.93
- Yupelri (Drug) $101.26
- Vascepa (Drug) $96.86
- LINZESS (Drug) $96.85
- APTIMA (Device) $88.14
- JANUVIA (Drug) $87.44
- JARDIANCE (Drug) $85.35
- UBRELVY (Drug) $78.52
- XARELTO (Drug) $76.86
- ANORO (Drug) $72.09
- Prolia (Biological) $68.31
- Saxenda (Drug) $62.95
- NEXPLANON (Drug) $50.52
- ELIQUIS (Drug) $46.67
- PRALUENT (Drug) $45.06
- INVOKANA (Drug) $44.53
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Athens
Farris Johnson, Md, MD
Family Medicine — Payments: $30,847
Family Medicine $30,847
Timothy Law, Do, DO
Family Medicine — Payments: $18,254
Family Medicine $18,254
Dr. Henry Morris, M.d, M.D
Family Medicine — Payments: $16,624
Family Medicine $16,624
Alvin Wilson, D.o, D.O
Family Medicine — Payments: $13,833
Family Medicine $13,833
Dr. James Shiver, M.d, M.D
Family Medicine — Payments: $13,306
Family Medicine $13,306
Dr. Paul Haver, M.d, M.D
Family Medicine — Payments: $11,681
Family Medicine $11,681